Patenting Personalized Medicine Inventions after Myriad
Patenting Personalized Medicine Inventions after Myriad
The Federal Circuit's recent decision in Assoc. for Mol. Pathology v. USPTO (2010-1406) (informally referred to as the Myriad decision), provides some clarity to entrepreneurs and scientists working in the personalized medicine industry.